These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 33485313

  • 1. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma.
    Li XS, Nie KC, Zheng ZH, Zhou RS, Huang YS, Ye ZJ, He F, Tang Y.
    BMC Cancer; 2021 Jan 23; 21(1):96. PubMed ID: 33485313
    [Abstract] [Full Text] [Related]

  • 2. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
    Yang K, Wu Y.
    BMC Cancer; 2021 Feb 06; 21(1):128. PubMed ID: 33549049
    [Abstract] [Full Text] [Related]

  • 3. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
    Huang G, Zhang J, Gong L, Liu D, Wang X, Chen Y, Guo S.
    Med Sci Monit; 2021 Mar 04; 27():e929524. PubMed ID: 33661858
    [Abstract] [Full Text] [Related]

  • 4. System analysis of FHIT in LUAD and LUSC: The expression, prognosis, gene regulation network, and regulation targets.
    Situ Y, Gao R, Lei L, Deng L, Xu Q, Shao Z.
    Int J Biol Markers; 2022 Jun 04; 37(2):158-169. PubMed ID: 35254116
    [Abstract] [Full Text] [Related]

  • 5. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL, Gong Y, Zhao DP.
    Eur Rev Med Pharmacol Sci; 2018 Dec 04; 22(24):8731-8739. PubMed ID: 30575913
    [Abstract] [Full Text] [Related]

  • 6. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y, Wang M, Liu B.
    J Cell Physiol; 2019 Apr 04; 234(4):4454-4459. PubMed ID: 30317601
    [Abstract] [Full Text] [Related]

  • 7. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
    Wei R, Wang Z, Zhang Y, Wang B, Shen N, E L, Li X, Shang L, Shang Y, Yan W, Zhang X, Ma W, Wang C.
    BMC Med Genomics; 2020 Aug 14; 13(1):112. PubMed ID: 32795325
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.
    Shi S, Xu M, Xi Y.
    Aging (Albany NY); 2020 Nov 24; 12(23):23917-23930. PubMed ID: 33237038
    [Abstract] [Full Text] [Related]

  • 10. The increased expression and aberrant methylation of SHC1 in non-small cell lung cancer: Integrative analysis of clinical and bioinformatics databases.
    Liang Y, Lei Y, Du M, Liang M, Liu Z, Li X, Gao Y.
    J Cell Mol Med; 2021 Jul 24; 25(14):7039-7051. PubMed ID: 34117717
    [Abstract] [Full Text] [Related]

  • 11. Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single-cell transcriptomic analysis: Implications for distinct immunotherapy outcomes.
    Fang X, Li D, Wan S, Hu J, Zhang P, Jie D, Chen L, Jiang G, Song N.
    J Gene Med; 2024 Jun 24; 26(6):e3694. PubMed ID: 38847309
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma.
    Xu Y, She Y, Li Y, Li H, Jia Z, Jiang G, Liang L, Duan L.
    Biomed Pharmacother; 2020 May 24; 125():109859. PubMed ID: 32036209
    [Abstract] [Full Text] [Related]

  • 15. Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles.
    Wang W, Wang S, Chu X, Liu H, Xiang M.
    J Comput Biol; 2020 Jul 24; 27(7):1041-1054. PubMed ID: 31710242
    [Abstract] [Full Text] [Related]

  • 16. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
    Li R, Yin YH, Jin J, Liu X, Zhang MY, Yang YE, Qu YQ.
    Int J Med Sci; 2020 Jul 24; 17(6):773-786. PubMed ID: 32218699
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
    Gao C, Zhuang J, Zhou C, Ma K, Zhao M, Liu C, Liu L, Li H, Feng F, Sun C.
    J Cell Physiol; 2019 May 24; 234(5):6519-6528. PubMed ID: 30246311
    [Abstract] [Full Text] [Related]

  • 18. Differential MUC22 expression by epigenetic alterations in human lung squamous cell carcinoma and adenocarcinoma.
    Lin S, Tian C, Li J, Liu B, Ma T, Chen K, Gong W, Wang JM, Huang J.
    Oncol Rep; 2021 May 24; 45(5):. PubMed ID: 33786615
    [Abstract] [Full Text] [Related]

  • 19. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
    Ning J, Jiang S, Li X, Wang Y, Deng X, Zhang Z, He L, Wang D, Jiang Y.
    BMC Pulm Med; 2021 Jun 10; 21(1):199. PubMed ID: 34112123
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
    Ke D, Guo Q, Fan TY, Xiao X.
    Cancer Biother Radiopharm; 2021 Apr 10; 36(3):280-291. PubMed ID: 33112657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.